The multiplex pcr assays market size has grown rapidly in recent years. It will grow from $1.7 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to rising burden of infectious diseases, increasing adoption of molecular diagnostics, limitations of singleplex pcr testing, growing demand for rapid diagnostic results, expansion of diagnostic laboratory infrastructure.
The multiplex pcr assays market size is expected to see rapid growth in the next few years. It will grow to $3.17 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to growing focus on early disease detection, rising demand for comprehensive diagnostic solutions, expansion of personalized medicine approaches, increasing investments in molecular diagnostics, growing adoption of multiplex assays in routine testing. Major trends in the forecast period include rising adoption of multiplex testing for infectious diseases, increasing demand for high-throughput diagnostic assays, growing use of syndromic testing panels, expansion of multiplex pcr in clinical diagnostics, increasing preference for cost-effective multi-target assays.
The growing demand for diagnostic testing is projected to drive the expansion of the multiplex PCR assay market. Diagnostic testing encompasses procedures or tests used to determine the presence or absence of diseases or conditions in patients. The increasing prevalence of chronic illnesses, such as cancer and diabetes, necessitates early and precise diagnosis for effective management. Furthermore, the emphasis on preventive healthcare promotes routine testing to identify potential health issues early. Multiplex PCR assays enable the simultaneous detection and analysis of multiple pathogens or genetic markers from a single sample, thereby enhancing the efficiency and thoroughness of diagnostic testing. For example, in July 2024, the National Health Service (NHS) reported that diagnostic activity surpassed pre-pandemic levels in 2023, with a 21% rise in tests conducted in May 2024 compared to the previous year. Additionally, 2.4 million diagnostic tests were performed in May 2024. This rising demand for diagnostic testing is expected to drive the growth of the multiplex PCR assay market.
Key players in the multiplex PCR assays market are focusing on integrating automation, such as next-generation quantitative PCR (qPCR) systems, to enhance precise and flexible nucleic acid quantification for advanced clinical diagnostics and public health. Next-generation qPCR systems provide high-throughput, accurate, and simultaneous detection of multiple targets, thus improving diagnostic accuracy and efficiency. For instance, in November 2023, Roche Diagnostics Corporation, a Swiss-based diagnostic system solutions provider, introduced the LightCycler PRO System. This next-generation qPCR platform offers high-throughput, precise, and simultaneous detection of multiple targets, featuring improved temperature uniformity, advanced software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays. This launch exemplifies the incorporation of automation in the multiplex PCR assays market, advancing clinical diagnostics and public health.
In July 2023, QIAGEN N.V., a Germany-based biotechnology company, partnered with Niba Labs. This partnership aims to advance research in genomic testing and personalized medicine by providing cutting-edge tools, data analysis, and expertise to foster innovation in biotechnology and healthcare. Niba Labs, a US-based biotechnology company, specializes in developing and manufacturing products for genomic research, molecular diagnostics, and personalized medicine.
Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, NanoString Technologies, Standard BioTools Inc, Agena Bioscience, Fluidigm Corporation.
North America was the largest region in the multiplex PCR assays market in 2025. The regions covered in the multiplex pcr assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the multiplex pcr assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the multiplex pcr assays market by increasing costs for imported reagents, enzymes, consumables, and analytical instruments. These impacts are most evident in north america and asia-pacific, where laboratories depend heavily on globally sourced molecular diagnostics components. Elevated costs have affected pricing and procurement decisions for diagnostic centers and research institutes. On the positive side, tariffs have encouraged local manufacturing, regional reagent production, and supply chain diversification, strengthening long-term market resilience.
The multiplex pcr assays market research report is one of a series of new reports that provides multiplex pcr assays market statistics, including multiplex pcr assays industry global market size, regional shares, competitors with a multiplex pcr assays market share, detailed multiplex pcr assays market segments, market trends and opportunities, and any further data you may need to thrive in the multiplex pcr assays industry. This multiplex pcr assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Multiplex PCR assays are advanced polymerase chain reaction techniques designed to simultaneously amplify and detect multiple DNA or RNA targets within a single reaction. This approach significantly enhances efficiency by enabling the analysis of various genetic markers or pathogens concurrently, offering comprehensive and cost-effective results.
The primary types of multiplex PCR assays include planar assays and bead-based assays. Planar assays are conducted on flat surfaces or platforms, such as microplates or slides, where arrays of probes are affixed to detect multiple targets in a single sample, facilitating efficient and high-throughput analysis. The product and service offerings encompass consumables, instruments, software, and services applicable to disease diagnosis, research and development, among other areas. End users of these technologies include biopharmaceutical companies, clinical research organizations, academic research institutes, and diagnostic centers.
The multiplex PCR assays market consists of sales of reverse transcription multiplex PCR (RT-multiplex PCR), digital multiplex PCR, end-point multiplex PCR, multiplex ligation-dependent probe amplification (MLPA), and probe-based multiplex PCR. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The multiplex pcr assays market size is expected to see rapid growth in the next few years. It will grow to $3.17 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to growing focus on early disease detection, rising demand for comprehensive diagnostic solutions, expansion of personalized medicine approaches, increasing investments in molecular diagnostics, growing adoption of multiplex assays in routine testing. Major trends in the forecast period include rising adoption of multiplex testing for infectious diseases, increasing demand for high-throughput diagnostic assays, growing use of syndromic testing panels, expansion of multiplex pcr in clinical diagnostics, increasing preference for cost-effective multi-target assays.
The growing demand for diagnostic testing is projected to drive the expansion of the multiplex PCR assay market. Diagnostic testing encompasses procedures or tests used to determine the presence or absence of diseases or conditions in patients. The increasing prevalence of chronic illnesses, such as cancer and diabetes, necessitates early and precise diagnosis for effective management. Furthermore, the emphasis on preventive healthcare promotes routine testing to identify potential health issues early. Multiplex PCR assays enable the simultaneous detection and analysis of multiple pathogens or genetic markers from a single sample, thereby enhancing the efficiency and thoroughness of diagnostic testing. For example, in July 2024, the National Health Service (NHS) reported that diagnostic activity surpassed pre-pandemic levels in 2023, with a 21% rise in tests conducted in May 2024 compared to the previous year. Additionally, 2.4 million diagnostic tests were performed in May 2024. This rising demand for diagnostic testing is expected to drive the growth of the multiplex PCR assay market.
Key players in the multiplex PCR assays market are focusing on integrating automation, such as next-generation quantitative PCR (qPCR) systems, to enhance precise and flexible nucleic acid quantification for advanced clinical diagnostics and public health. Next-generation qPCR systems provide high-throughput, accurate, and simultaneous detection of multiple targets, thus improving diagnostic accuracy and efficiency. For instance, in November 2023, Roche Diagnostics Corporation, a Swiss-based diagnostic system solutions provider, introduced the LightCycler PRO System. This next-generation qPCR platform offers high-throughput, precise, and simultaneous detection of multiple targets, featuring improved temperature uniformity, advanced software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays. This launch exemplifies the incorporation of automation in the multiplex PCR assays market, advancing clinical diagnostics and public health.
In July 2023, QIAGEN N.V., a Germany-based biotechnology company, partnered with Niba Labs. This partnership aims to advance research in genomic testing and personalized medicine by providing cutting-edge tools, data analysis, and expertise to foster innovation in biotechnology and healthcare. Niba Labs, a US-based biotechnology company, specializes in developing and manufacturing products for genomic research, molecular diagnostics, and personalized medicine.
Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, NanoString Technologies, Standard BioTools Inc, Agena Bioscience, Fluidigm Corporation.
North America was the largest region in the multiplex PCR assays market in 2025. The regions covered in the multiplex pcr assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the multiplex pcr assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the multiplex pcr assays market by increasing costs for imported reagents, enzymes, consumables, and analytical instruments. These impacts are most evident in north america and asia-pacific, where laboratories depend heavily on globally sourced molecular diagnostics components. Elevated costs have affected pricing and procurement decisions for diagnostic centers and research institutes. On the positive side, tariffs have encouraged local manufacturing, regional reagent production, and supply chain diversification, strengthening long-term market resilience.
The multiplex pcr assays market research report is one of a series of new reports that provides multiplex pcr assays market statistics, including multiplex pcr assays industry global market size, regional shares, competitors with a multiplex pcr assays market share, detailed multiplex pcr assays market segments, market trends and opportunities, and any further data you may need to thrive in the multiplex pcr assays industry. This multiplex pcr assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Multiplex PCR assays are advanced polymerase chain reaction techniques designed to simultaneously amplify and detect multiple DNA or RNA targets within a single reaction. This approach significantly enhances efficiency by enabling the analysis of various genetic markers or pathogens concurrently, offering comprehensive and cost-effective results.
The primary types of multiplex PCR assays include planar assays and bead-based assays. Planar assays are conducted on flat surfaces or platforms, such as microplates or slides, where arrays of probes are affixed to detect multiple targets in a single sample, facilitating efficient and high-throughput analysis. The product and service offerings encompass consumables, instruments, software, and services applicable to disease diagnosis, research and development, among other areas. End users of these technologies include biopharmaceutical companies, clinical research organizations, academic research institutes, and diagnostic centers.
The multiplex PCR assays market consists of sales of reverse transcription multiplex PCR (RT-multiplex PCR), digital multiplex PCR, end-point multiplex PCR, multiplex ligation-dependent probe amplification (MLPA), and probe-based multiplex PCR. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Multiplex PCR Assays Market Characteristics
3. Multiplex PCR Assays Market Supply Chain Analysis
4. Global Multiplex PCR Assays Market Trends and Strategies
5. Multiplex PCR Assays Market Analysis of End Use Industries
7. Global Multiplex PCR Assays Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Multiplex PCR Assays Total Addressable Market (TAM) Analysis for the Market
9. Multiplex PCR Assays Market Segmentation
10. Multiplex PCR Assays Market Regional and Country Analysis
11. Asia-Pacific Multiplex PCR Assays Market
12. China Multiplex PCR Assays Market
13. India Multiplex PCR Assays Market
14. Japan Multiplex PCR Assays Market
15. Australia Multiplex PCR Assays Market
16. Indonesia Multiplex PCR Assays Market
17. South Korea Multiplex PCR Assays Market
18. Taiwan Multiplex PCR Assays Market
19. South East Asia Multiplex PCR Assays Market
20. Western Europe Multiplex PCR Assays Market
21. UK Multiplex PCR Assays Market
22. Germany Multiplex PCR Assays Market
23. France Multiplex PCR Assays Market
24. Italy Multiplex PCR Assays Market
25. Spain Multiplex PCR Assays Market
26. Eastern Europe Multiplex PCR Assays Market
27. Russia Multiplex PCR Assays Market
28. North America Multiplex PCR Assays Market
29. USA Multiplex PCR Assays Market
30. Canada Multiplex PCR Assays Market
31. South America Multiplex PCR Assays Market
32. Brazil Multiplex PCR Assays Market
33. Middle East Multiplex PCR Assays Market
34. Africa Multiplex PCR Assays Market
36. Multiplex PCR Assays Market Competitive Landscape and Company Profiles
37. Multiplex PCR Assays Market Other Major and Innovative Companies
40. Multiplex PCR Assays Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Multiplex PCR Assays Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses multiplex pcr assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for multiplex pcr assays? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The multiplex pcr assays market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Assay Type: Planar Assay; Bead Based Assay2) By Product And Services: Consumables; Instruments; Software And Services
3) By Application: Disease Diagnosis; Research And Development; Other Applications
4) By End User: Biopharmaceutical Companies; Clinical Research Organizations; Academic Research Institutes; Diagnostic Centers; Other End Users
Subsegments:
1) By Planar Assay: Microarray-Based Assays; Dna Chip-Based Assays2) By Bead Based Assay: Luminex Xmap Assays; Magpix Assays; Flow Cytometry-Based Bead Assays
Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc; Abbott Laboratories; Danaher Corporation; Merck KGaA; Siemens Healthineers; Becton Dickinson and Company; Agilent Technologies Inc; PerkinElmer Inc; Bio-Rad Laboratories Inc; QIAGEN NV; Tecan Group Ltd; DiaSorin SpA; Bio-Techne Corporation; Promega Corporation; Randox Laboratories Ltd; BioFire Diagnostics Inc; Seegene Inc; NanoString Technologies; Standard BioTools Inc; Agena Bioscience; Fluidigm Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Multiplex PCR Assays market report include:- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc
- Abbott Laboratories
- Danaher Corporation
- Merck KGaA
- Siemens Healthineers
- Becton Dickinson and Company
- Agilent Technologies Inc
- PerkinElmer Inc
- Bio-Rad Laboratories Inc
- QIAGEN NV
- Tecan Group Ltd
- DiaSorin SpA
- Bio-Techne Corporation
- Promega Corporation
- Randox Laboratories Ltd
- BioFire Diagnostics Inc
- Seegene Inc
- NanoString Technologies
- Standard BioTools Inc
- Agena Bioscience
- Fluidigm Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.93 Billion |
| Forecasted Market Value ( USD | $ 3.17 Billion |
| Compound Annual Growth Rate | 13.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
